Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-25-001090
Filing Date
2025-02-18
Accepted
2025-02-18 14:17:09
Documents
34
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q agtx_10q.htm   iXBRL 10-Q 490347
2 CERTIFICATION agtx_ex311.htm EX-31.1 10589
3 CERTIFICATION agtx_ex312.htm EX-31.2 11089
4 CERTIFICATION agtx_ex321.htm EX-32.1 4135
  Complete submission text file 0001477932-25-001090.txt   1842662

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA agtx-20241231.xsd EX-101.SCH 17321
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE agtx-20241231_lab.xml EX-101.LAB 113625
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE agtx-20241231_cal.xml EX-101.CAL 25720
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agtx-20241231_pre.xml EX-101.PRE 88841
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE agtx-20241231_def.xml EX-101.DEF 34792
37 EXTRACTED XBRL INSTANCE DOCUMENT agtx_10q_htm.xml XML 149552
Mailing Address 32932 PACIFIC COAST HIGHWAY #14-254 DANA POINT CA 92629
Business Address 32932 PACIFIC COAST HIGHWAY #14-254 DANA POINT CA 92629 321-229-2014
Agentix Corp. (Filer) CIK: 0001603345 (see all company filings)

EIN.: 462876282 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-55383 | Film No.: 25634313
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)